Cosciens Biopharma logo

Cosciens Biopharma Share Price (NASDAQ: CSCI)

$3.04

-0.13

(-4.1%)

Last updated on

Check the interactive Cosciens Biopharma Stock chart to analyse performance

Cosciens Biopharma stock performance

as on August 30, 2025 at 1:28 am IST

  • Today's Low:$3.01
    Today's High:$3.04

    Day's Volatility :0.99%

  • 52 Weeks Low:$1.96
    52 Weeks High:$4.61

    52 Weeks Volatility :57.44%

Cosciens Biopharma Stock Returns

PeriodCosciens Biopharma IncIndex (Russel 2000)
3 Months
-17.53%
0.0%
6 Months
11.48%
0.0%
1 Year
-24.18%
0.0%
3 Years
-50.98%
-4.7%

Cosciens Biopharma Inc Key Stats

Check Cosciens Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.17
Open
$3.01
Today's High
$3.04
Today's Low
$3.01
Market Capitalization
$10.1M
Today's Volume
$2.9K
52 Week High
$4.6054
52 Week Low
$1.96
Revenue TTM
$9.4M
EBITDA
$-9.2M
Earnings Per Share (EPS)
$-6.54
Profit Margin
-199.55%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-113.08%

Stock Returns calculator for Cosciens Biopharma Stock including INR - Dollar returns

The Cosciens Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cosciens Biopharma investment value today

Current value as on today

₹81,858

Returns

₹18,142

(-18.14%)

Returns from Cosciens Biopharma Stock

₹23,426 (-23.43%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cosciens Biopharma Stock

100%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cosciens Biopharma Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Cosciens Biopharma Stock

Rating
Trend

Cosciens Biopharma Stock Insights

  • Price Movement

    In the last 7 days, CSCI stock has moved down by -8.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.49M → 2.74M (in $), with an average increase of 45.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -6.73M → -2.70M (in $), with an average increase of 59.8% per quarter
  • CSCI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 94.8%
  • Price to Sales

    ForCSCI every $1 of sales, investors are willing to pay $1.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Cosciens Biopharma Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$13.8M
↑ 92.96%
Net Income
$-15.3M
↑ 339.28%
Net Profit Margin
-111.07%
↓ 62.28%

Cosciens Biopharma Technicals Summary

Sell

Neutral

Buy

Cosciens Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cosciens Biopharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cosciens Biopharma Inc logo
-22.82%
11.48%
-24.18%
-50.98%
-50.98%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Cosciens Biopharma Inc

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce inflammation for the healthcare and cosmetic industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as for endocrinology and oncology indications. The company sells its products through its distribution network. It has license agreements with Pharmanovia, MegaPharm Ltd., ER Kim Pharmaceuticals Bulgaria Eood, and NK MEDITECH Ltd, as well as Agriculture Canada and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Organization
Cosciens Biopharma
Employees
40
CEO
Ms. Anna Elizabeth Biehn
Industry
Miscellaneous

Key Management of Cosciens Biopharma Inc

NameTitle
Mr. Giuliano La Fratta
Senior VP of Finance & CFO
Mr. Michel Regnier P. Eng.
Senior VP of Technical operations, MD of Ceapro Inc. & CTO
Dr. Michael Teifel Ph.D.
Senior Vice President of GmbH & Chief Scientific Officer
Dr. Matthias Gerlach
Senior Vice President Manufacturing and Supply Chain & Head of Production
Ms. Anna Elizabeth Biehn
Chief Executive Officer

Important FAQs about investing in CSCI Stock from India :

What is Cosciens Biopharma share price today?

Cosciens Biopharma share price today is $3.04 as on at the close of the market. Cosciens Biopharma share today touched a day high of $3.04 and a low of $3.01.

What is the 52 week high and 52 week low for Cosciens Biopharma share?

Cosciens Biopharma share touched a 52 week high of $4.61 and a 52 week low of $1.96. Cosciens Biopharma stock price today i.e. is closed at $3.04, lower by 33.99% versus the 52 week high.

How to invest in Cosciens Biopharma Stock (CSCI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cosciens Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cosciens Biopharma Shares that will get you 0.4934 shares as per Cosciens Biopharma share price of $3.04 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Cosciens Biopharma Stock (CSCI) from India?

Indian investors can start investing in Cosciens Biopharma (CSCI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cosciens Biopharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cosciens Biopharma share’s latest price of $3.04 as on August 30, 2025 at 1:28 am IST, you will get 3.2895 shares of Cosciens Biopharma. Learn more about fractional shares .

What are the returns that Cosciens Biopharma has given to Indian investors in the last 5 years?

Cosciens Biopharma stock has given -50.98% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?